Crossmark

Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine

Crossref DOI link: https://doi.org/10.1007/s13311-020-00967-7

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Andreou, Anna P.

Leese, Charlotte

Greco, Rosaria

Demartini, Chiara

Corrie, Eve

Simsek, Deniz

Zanaboni, Anna

Koroleva, Ksenia

Lloyd, Joseph O.

Lambru, Giorgio

Doran, Ciara

Gafurov, Oleg

Seward, Elizabeth

Giniatullin, Rashid

Tassorelli, Cristina

Davletov, Bazbek https://orcid.org/0000-0003-4658-3275
Funding

Funding for this research was provided by:

Medical Research Council (MR/K022539/1, MC_PC_16058)

Migraine Research Foundation

Finnish Academy (325392)

Kazan Federal University (0671-2020-0059)

Ministero della Salute
License Information

Text and Data Mining valid from 2021-01-01

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2020-11-17
More Information

This article is maintained by: Elsevier

Article Title: Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00967-7

Content Type: article

Copyright: Copyright © 2021 The authors. Published by Elsevier B.V. All rights reserved.